Purchase Order 75N94025P00074
Award Date
12/24/24
Potential Completion Date
12/23/25
Potential Value
$144K
Funding Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing equipment and consumables, to provide a NextSeq 2000 Sequencing System and associated services for $248,675.00. The contract has no set-aside designation. This purchase order was issued under a sole source solicitation, as the NextSeq 2000 system is the only platform...
This is a firm fixed price delivery order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $25,459.20 contract is for the provision of Illumina's genomic sequencing instruments, reagents, and related services to support NIAAA's research activities. Illumina is a manufacturer of genetic analysis products and has previously provided similar goods and services to other federal agencies such as...
This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for maintenance support services on NIDA's existing Illumina sequencing systems. The contract has a ceiling value of $144,898.72 and an ultimate completion date of December 4, 2017. This purchase order is not associated with a set-aside program. Illumina, a manufacturer of sequencing and analysis products, has...
This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and consumables. The $729,384.93 contract supports the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to NIDA. This appears to be a standalone contract award, rather than being associated with a...
This federal contract award, valued at $22,464.00, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is a firm fixed-price delivery order with no set-aside designation. Illumina will provide NIAAA with a range of genomic sequencing platforms, reagents, consumables, maintenance services, and technical support. This contract is part of...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $93,525.44 contract provides a 12-month silver support plan for two NextSeq 2000 sequencing systems. No set-aside was used. Illumina is a manufacturer and provider of genomic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from the NIH, CDC,...
This is a firm fixed-price task order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is for the procurement of Illumina reagents and consumables, specifically Quote #00015178.5, with a ceiling value of $47,675.57 and a period of performance through December 30, 2025. The contract does...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the basic product care maintenance of a NextSeq S/N NSS00515 sequencing system, including a 4-year service plan. The total ceiling value of the contract is $137,565.03. Illumina, a manufacturer of DNA sequencing instruments and reagents, has previously received other prime...
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance and repair services of Illumina's NovaSeq 6000 sequencing equipment. The contract has a ceiling value of $43,380.00 and a period of performance ending on October 12, 2025. The contract was awarded on a sole-source basis, as Illumina is the original equipment manufacturer of the NovaSeq 6000 sequencer....
This is a firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Illumina, Inc. The $133,624.15 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. The contract has a period of performance through...